Total Return Level Chart

Historical Total Return Level Data

View and export this data back to 1990. Start Trial.
Date Value
November 19, 2026 270.81
November 18, 2026 274.87
November 17, 2026 264.42
November 16, 2026 260.36
November 13, 2026 256.49
November 12, 2026 253.27
November 11, 2026 258.53
November 10, 2026 256.83
November 09, 2026 255.88
November 06, 2026 249.50
November 05, 2026 251.62
November 04, 2026 247.85
November 03, 2026 231.44
November 02, 2026 232.63
October 30, 2026 231.14
October 29, 2026 233.82
October 28, 2026 229.84
October 27, 2026 229.87
October 26, 2026 226.23
October 23, 2026 225.39
October 22, 2026 225.87
October 21, 2026 215.65
October 20, 2026 216.89
October 19, 2026 214.46
October 16, 2026 215.70
Date Value
October 15, 2026 212.04
October 14, 2026 203.89
October 13, 2026 205.79
October 12, 2026 207.87
October 09, 2026 206.92
October 08, 2026 205.38
October 07, 2026 205.86
October 06, 2026 206.29
October 05, 2026 207.11
October 02, 2026 205.26
October 01, 2026 208.55
September 30, 2026 206.78
September 29, 2026 208.90
September 28, 2026 210.65
September 25, 2026 201.87
September 24, 2026 198.60
September 23, 2026 201.34
September 22, 2026 206.55
September 21, 2026 206.39
September 18, 2026 205.92
September 17, 2026 207.69
September 16, 2026 211.68
September 15, 2026 213.37
September 14, 2026 215.48
September 11, 2026 216.62

Total Return Level Definition

The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.

Read full definition.

Total Return Level Range, Past 5 Years

View Total Return Level Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Return Level Benchmarks

View Total Return Level Benchmarks
Start Trial
Globus Medical, Inc. 68.60
Veracyte, Inc. 25.04
IDEXX Laboratories, Inc. 689.65
Penumbra, Inc. 320.01
Abbott Laboratories 234.27